Instil Bio Capital Expenditures (CapEx) Growth & History (TIL)

Instil Bio's capital expenditures (capex) was $10.0M for fiscal 2025.

View full Instil Bio company overview

Instil Bio annual capital expenditures (capex) history

Instil Bio annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$10.0M$10.0M
20242024-12-31$0−$20.7M
20232023-12-31$20.7M−$63.9M−75.57%
20222022-12-31$84.6M$26.8M+46.27%
20212021-12-31$57.8M$7.0M+13.80%
20202020-12-31$50.8M

Instil Bio capital expenditures (capex) trends

Over the last five fiscal years, Instil Bio's capital expenditures (capex) decreased from $50.8M to $10.0M, a change of −$40.8M. The latest reported quarter, Q4 2024, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Instil Bio source filings ↗

Community posts

It’s quiet here.

No posts about TIL yet. Start the conversation.

Write the first post